Treatment of hemangioma with an angiogenesis inhibitor pingyangmycin

Indian Pediatrics

Volumn 37, Issue 6, 2000, Pages 636-639

  Licun, Wu ^a   Gongjia, Sun ^a  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; BLEOMYCIN A5; HEPARIN; HYDROCORTISONE; METHYLCELLULOSE;

ARTICLE; CHICK EMBRYO; CHORIOALLANTOIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEMANGIOMA; HUMAN; INFANT; MALE; NONHUMAN; PRESCHOOL CHILD; TUMOR VASCULARIZATION;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BLEOMYCIN; CHICK EMBRYO; FEMALE; HEAD AND NECK NEOPLASMS; HEMANGIOMA; HUMANS; INFANT; MALE;

EID: 0033934506     PISSN: 00196061     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Oikawa T, Hirotani K, Ogasawara H, Katayama T, Ashinofuse H, Shimamura M, et al. Inhibition of angiogenesis by bleomycin and its copper complex. Chem Pharm Bull 1990; 38: 1790-1792.
2. Locopo N, Fanelli M, Gasparini G. Clinical significance of angiogenic factors in breast cancer. Breast Cancer Res Treat 1998; 52: 159-173.
3. Dhanabal M, Ramchandran R, Volk R, Stillman IE, Lombardo M, Iruela-Arispe ML, et al. Endostatin: Yeast production, mutants, and antitumor effect in renal cell carcinoma. Cancer Res 1999; 59: 189-197.
4. Marcia B. Designing therapies that target tumor blood vessels. Cancer Res 1997; 257: 482-484.
5. Chang J, Most D, Bresnick S, Bresnick S, Mehrara B, Steinbrech DS, et al. Proliferative hemangiomas: Analysis of cytokine gene expression and angiogenesis. Plast Reconstr Surg 1999; 103: 1-9.
6. Bielenberg DR, Bucana CD, Sanchez R, Mulliken JB, Folkman J, Fidler IJ. Progressive growth of infantile cutaneous hemangioma is directly correlated with hyperplasia and angiogenesis of adjacent epidermis and inversely correlated with expression of the endogenous angiogenesis inhibitor, IFN-beta. Int J Oncol 1999; 14: 401-8.
7. Lymboussaki A, Partenen TA, Olofsson B, Thomas-Crusells J, Fletcher CD, de Waal RM, et al. Expression of the vascular endothelial growth factor C receptor VEGFR-3 in lymphatic endothelium of the skin and in vascular tumors. Am J Pathol 1998; 153: 395-403.
8. Dosquet C, Coudert MC, Wassef M, Enjolras O, Drouet L. Importance of bFGF ("basic fibroblast growth factor") for diagnosis and treatment of hemangioma. Ann Dermatol Venereol 1998; 125: 313-316.
9. Benjamin LE, Keshet E. Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: Induction of endothelial cell shedding and regression of hemangio-blastoma-like vessels by VEGF withdrawal. Proc Natl Acad Sci USA 1997; 94: 8761-8766.
10. Liekens S, Verbeken E, Vandepute M, Vandeputte M, De Clercq E, Neyts J. A novel animal model for hemangioma: Inhibition of hemangioma development by the angiogenesis inhibitor TNP-470. Cancer Res 1999; 59: 2376-2383.
11. Strarmann R, Krieg M, Haas R, Plate KH. Putative control of angiogenesis in hemangio-blastomas by the von Hippel-Lindau tumor suppressor gene. J Neuropathol Exp Neurol 1997; 56: 1241-1252.
12. White CW, Henry MS, Edmond CC, Harry W, Leland LF. Treatment of pulmonary hemangioma with recombinant interferon alfa-2a. N Engl J Med 1989; 320: 1197-1200.